Skip to main content
The sample recordsFamily 9 · Patient Monitoring (ICU/Ward)

NAVOY Sepsis at Skane University Hospital

PilotRobust evidence

NAVOY Sepsis predicts sepsis onset three hours in advance from four hours of routinely collected vital parameters, blood gas and laboratory values in ICU patients.

ReviewedReviewed by AIH Labpubmed.ncbi.nlm.nih.gov · PMID:38245375
What this means:
The source has been read and our reading of it confirmed — the classifications that let this record be compared with others, the AI product, and the clinical use. That is a check of our work, not a judgement on the AI.
What happens next:
Nothing, unless this use case is taken up for assessment. Then the AI product and its clinical use are examined together in seven sections — purpose, evidence, CE conformity, legal duties, ethics, safety, and what a hospital must have in place — each signed by a named institution.
Checked by:
A named reviewer at the AIH Lab. This is an independent check: neither the organisation nor the vendor did it.
  1. Submitted
  2. 2Curated
  3. 3Maturing
  4. 4Validated
  5. 5Scaled
Sweden
Country
Clinical context
Clinical problem
Predict a future risk
Point of care
Monitoring
Nature of AI output
An alert
Clinical specialty
Intensive care
Care setting
Intensive care unit
Patient population
304 adult ICU patients (Dec 2020 - Sep 2021), including Covid-19 patients
Intended use
NAVOY Sepsis predicts sepsis onset three hours in advance from four hours of routinely collected vital parameters, blood gas and laboratory values in ICU patients.
Full study description

EUROPEAN and RANDOMISED — the strongest study design in this batch. Journal of Critical Care 2024 (PMID 38245375): a prospective randomised clinical validation at the ICU of Skane University Hospital Malmo, with a silent-mode arm. Authors report the algorithm "could predict the development of sepsis, according to the Sepsis-3 criteria, three hours before sepsis onset with high performance: accuracy 0.79; sensitivity 0.80; and specificity 0.78." IMPORTANT CAVEAT: the trial validates PROGNOSTIC ACCURACY only — it reports no patient-outcome difference (mortality, length of stay, antibiotic timing) between arms. Single centre, n=304. First and last authors are affiliated with the vendor AlgoDx AB. Recorded as pilot: provisional, time-boxed research use rather than routine service.

Technology
AI technique
Classical machine learning
Input data
Structured EHR data, Vital signs, Laboratory results
Output type
Alert
Autonomy level
Informs a human (advisory)
Model provenance
Vendor proprietary
Deployment
Status
Pilot
Country
Sweden
Regulatory & governance
Data identifiability
Not stated in the source

Similar deployments

AI
Looking for close matches in the Library…

Evidence records

Studies and evaluations attached to this use case.

  • Prospective clinical trial

    Accuracy: 0.79

    Population: 304 ICU patients, Skane University Hospital Malmo, randomised; sepsis prediction 3h before onset

    Source
  • Prospective clinical trial

    Sensitivity: 0.8

    Population: same cohort

    Source
  • Prospective clinical trial

    Specificity: 0.78

    Population: same cohort

    Source

Contributors

Deploying organisation
Skåne University Hospital · Hospital / health system · Sweden
AI vendor
AlgoDx AB · Sweden
Product name
NAVOY Sepsis